Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
ProShares Ultra Health Care (RXL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: RXL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type ETF | Historic Profit 16.15% | Avg. Invested days 54 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | ETF Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/24/2025 |
Key Highlights
Volume (30-day avg) - | Beta 1.08 | 52 Weeks Range 36.32 - 57.93 | Updated Date 06/29/2025 |
52 Weeks Range 36.32 - 57.93 | Updated Date 06/29/2025 |
Upturn AI SWOT
ProShares Ultra Health Care
ETF Overview
Overview
ProShares Ultra Health Care (RXL) seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health Care Index. It provides leveraged exposure to the health care sector.
Reputation and Reliability
ProShares is a well-known issuer of leveraged and inverse ETFs with a solid track record.
Management Expertise
ProShares specializes in complex investment strategies, indicating strong management expertise in managing leveraged ETFs.
Investment Objective
Goal
To seek daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health Care Index.
Investment Approach and Strategy
Strategy: The ETF employs a leveraged strategy, aiming to amplify the daily returns of the Dow Jones U.S. Health Care Index.
Composition The ETF's composition primarily consists of financial instruments designed to achieve 2x leveraged exposure to companies within the Dow Jones U.S. Health Care Index.
Market Position
Market Share: RXL's market share is relatively smaller compared to non-leveraged health care ETFs.
Total Net Assets (AUM): 55870000
Competitors
Key Competitors
- XLV
- VHT
- IXJ
- XHE
Competitive Landscape
The health care ETF market is dominated by broad, non-leveraged ETFs like XLV and VHT. RXL's leveraged nature provides higher potential returns but also significantly higher risk than its competitors. It's a niche product compared to broad market health care ETFs.
Financial Performance
Historical Performance: Historical performance data is highly dependent on the market conditions during the measured period and is affected by compounding and leverage effects.
Benchmark Comparison: Comparison to the underlying index (Dow Jones U.S. Health Care Index) is crucial, but remember RXL aims for 2x daily performance, not long-term tracking. Due to leverage, long term comparison may not be ideal.
Expense Ratio: 0.95
Liquidity
Average Trading Volume
The ETF's average trading volume is moderate but sufficient for most investors to trade without significant price impact.
Bid-Ask Spread
The bid-ask spread can vary, especially during volatile market conditions; investors should check current quotes before trading.
Market Dynamics
Market Environment Factors
Economic indicators, healthcare policy changes, pharmaceutical industry news, and overall market sentiment significantly impact RXL's performance.
Growth Trajectory
Growth trajectory is tied to the healthcare sector's performance and investor appetite for leveraged products.
Moat and Competitive Advantages
Competitive Edge
RXL's primary advantage is its leveraged exposure, providing a tool for investors seeking amplified daily returns in the healthcare sector. It offers a short-term tactical instrument for traders who believe the healthcare sector will increase on a particular day. However, the leveraged nature means that a decline in the healthcare sector will lead to amplified losses. Its expense ratio is relatively high which erodes returns.
Risk Analysis
Volatility
RXL exhibits high volatility due to its leveraged nature; small changes in the underlying index are magnified.
Market Risk
Market risk is significant; declines in the healthcare sector are amplified, potentially leading to substantial losses.
Investor Profile
Ideal Investor Profile
Suitable for sophisticated investors with a high-risk tolerance seeking short-term, tactical exposure to the healthcare sector.
Market Risk
Best suited for active traders seeking short-term gains and not for long-term investors or passive index followers.
Summary
ProShares Ultra Health Care (RXL) is a leveraged ETF designed to deliver twice the daily performance of the Dow Jones U.S. Health Care Index. Its leverage amplifies both gains and losses, making it a high-risk, high-reward investment. It is best suited for experienced traders with a short-term outlook on the health care sector. Investors should carefully consider the ETF's volatility and expense ratio before investing.
Peer Comparison
Sources and Disclaimers
Data Sources:
- ProShares website
- Morningstar
- ETF.com
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Leveraged ETFs are complex instruments and may not be suitable for all investors. Past performance is not indicative of future results. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ProShares Ultra Health Care
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.